Pharmafile Logo

Patients and data tracking

- PMLiVE

Ipsen receives CHMP recommendation for Cabometyx in neuroendocrine tumours

The number of patients newly diagnosed with NETs is believed to be on the rise

- PMLiVE

The Considered appoints Emily Knight-Kristoffersen as chief creative officer

Knight-Kristoffersen most recently served as the agency’s executive vice president, creative director

- PMLiVE

MHRA becomes founding member of HealthAI Global Regulatory Network

The network of health regulators will focus on the safe and effective use of AI in healthcare

- PMLiVE

J&J’s Darzalex recommended by CHMP to treat smouldering multiple myeloma

If approved, Darzalex would be the first therapy approved in the EU for SMM

- PMLiVE

New Alzheimer’s Treatments Are Driving a Shift in Earlier Detection and Clinician Education Engagement

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

Medscape Education

EU flag

EC approves argenx’s subcutaneous Vyvgart for rare autoimmune disease CIPD

The drug has been authorised as a monotherapy for adults with progressive or relapsing active cases

- PMLiVE

“Humanizing Healthcare, Humanizing Education: The Power of Patient Integration”

Victoria Harvey-Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & Engagement Conference

Medscape Education

- PMLiVE

Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s global pricing and market access team.

Petauri Evidence

- PMLiVE

Webinar: Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

An expert-led discussion exploring the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).

Petauri Evidence

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Datroway granted FDA accelerated approval for lung cancer

Approximately 226,650 new cases of lung cancer will be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links